Mapping the Relative Biological Effectiveness of Proton, Helium and Carbon Ions with High-Throughput Techniques.

charged particle therapy high-throughput techniques lung cancer cells relative biological effectiveness

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
05 Dec 2020
Historique:
received: 29 10 2020
revised: 26 11 2020
accepted: 04 12 2020
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 10 12 2020
Statut: epublish

Résumé

Large amounts of high quality biophysical data are needed to improve current biological effects models but such data are lacking and difficult to obtain. The present study aimed to more efficiently measure the spatial distribution of relative biological effectiveness (RBE) of charged particle beams using a novel high-accuracy and high-throughput experimental platform. Clonogenic survival was selected as the biological endpoint for two lung cancer cell lines, H460 and H1437, irradiated with protons, carbon, and helium ions. Ion-specific multi-step microplate holders were fabricated such that each column of a 96-well microplate is spatially situated at a different location along a particle beam path. Dose, dose-averaged linear energy transfer (LET

Identifiants

pubmed: 33291477
pii: cancers12123658
doi: 10.3390/cancers12123658
pmc: PMC7762185
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : Cancer Prevention and Research Institute of Texas
ID : RP150578
Organisme : NCI NIH HHS
ID : CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : CA187484
Pays : United States
Organisme : Cancer Prevention and Research Institute of Texas
ID : RP170067

Références

Sci Rep. 2020 Oct 30;10(1):19101
pubmed: 33127998
J Radiat Res. 2013 May;54(3):494-514
pubmed: 23266948
Phys Med Biol. 2020 Oct 21;:
pubmed: 33086208
Phys Med Biol. 2020 Oct 22;65(21):21RM02
pubmed: 32380492
J Radiat Res. 2005 Mar;46(1):51-7
pubmed: 15802859
Appl Radiat Isot. 2014 Jun;88:12-5
pubmed: 24799334
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):442-50
pubmed: 22099045
Cancer Res. 2005 Jan 1;65(1):113-20
pubmed: 15665286
Phys Med Biol. 2000 Nov;45(11):3299-317
pubmed: 11098905
Front Immunol. 2017 Feb 22;8:177
pubmed: 28275377
Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):475-81
pubmed: 19735871
Phys Med Biol. 2000 Nov;45(11):3319-30
pubmed: 11098906
Med Phys. 2017 Nov;44(11):6061-6073
pubmed: 28880368
Int J Part Ther. 2016 Winter;2(3):474-477
pubmed: 31772958
J Radiat Res. 2015 Jan;56(1):11-21
pubmed: 25190155
Radiat Res. 2012 Oct;178(4):341-56
pubmed: 22880622
Int J Radiat Biol. 1996 Jun;69(6):739-55
pubmed: 8691026
Sci Rep. 2015 May 18;5:9850
pubmed: 25984967
Radiat Environ Biophys. 1976 Oct 7;13(3):215-27
pubmed: 981514
Phys Med Biol. 2018 Dec 21;64(1):015008
pubmed: 30523805
Med Phys. 1998 Jul;25(7 Pt 1):1157-70
pubmed: 9682201
Med Phys. 2018 Nov;45(11):e925-e952
pubmed: 30421808
Acta Oncol. 2017 Nov;56(11):1367-1373
pubmed: 28826292
Phys Med Biol. 2010 Nov 21;55(22):6721-37
pubmed: 21030747
Med Phys. 2019 Mar;46(3):e53-e78
pubmed: 30661238
Phys Med Biol. 2014 Nov 21;59(22):R419-72
pubmed: 25361443
Med Phys. 2016 Feb;43(2):761-76
pubmed: 26843239
Radiat Oncol. 2013 Apr 15;8:91
pubmed: 23587329
Cancer. 2010 Aug 1;116(15):3740-8
pubmed: 20564091
Radiat Res. 2008 Apr;169(4):447-59
pubmed: 18363426
Int J Radiat Biol. 1996 Jun;69(6):729-38
pubmed: 8691025
Int J Radiat Biol. 1999 Nov;75(11):1357-64
pubmed: 10597910
Mol Chem Neuropathol. 1994 Feb-Apr;21(2-3):139-54
pubmed: 8086033
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):854-60
pubmed: 22483698
Radiat Oncol. 2015 Feb 27;10:55
pubmed: 25888875
Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):173-80
pubmed: 26279033
Sci Rep. 2018 Nov 2;8(1):16257
pubmed: 30390002
Phys Med Biol. 2020 Feb 12;65(4):045005
pubmed: 31968318
Phys Med Biol. 2015 Jul 07;60(13):5053-70
pubmed: 26061666
Phys Med Biol. 2015 Nov 7;60(21):8399-416
pubmed: 26459756
Radiat Oncol. 2015 Nov 04;10:223
pubmed: 26537797
Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1081-9
pubmed: 25832698
Acta Oncol. 2016 Jun;55(6):751-9
pubmed: 26750803
Phys Med Biol. 2020 Dec 04;65(23):235010
pubmed: 33274727
Cancers (Basel). 2017 Jun 09;9(6):
pubmed: 28598362
Radiat Res. 2006 Oct;166(4):629-38
pubmed: 17007551
Cancer Commun (Lond). 2020 Sep;40(9):406-421
pubmed: 32805063
Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):557-68
pubmed: 26460998
Nature. 2014 Apr 3;508(7494):133-8
pubmed: 24695279

Auteurs

Lawrence Bronk (L)

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Fada Guan (F)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Darshana Patel (D)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Duo Ma (D)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Benjamin Kroger (B)

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Xiaochun Wang (X)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Kevin Tran (K)

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Joycelyn Yiu (J)

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Clifford Stephan (C)

Texas A&M Institute of Biosciences and Technology High Throughput Research and Screening Center, Houston, TX 77030, USA.

Jürgen Debus (J)

National Center for Tumor Diseases, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany.

Amir Abdollahi (A)

National Center for Tumor Diseases, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany.
Heidelberger Ionenstrahl Therapiezentrum, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany.

Oliver Jäkel (O)

National Center for Tumor Diseases, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany.
Heidelberger Ionenstrahl Therapiezentrum, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany.

Radhe Mohan (R)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Uwe Titt (U)

Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

David R Grosshans (DR)

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Classifications MeSH